# Vxr, Inc.

- Location (FDA's records): Mchenry, IL
- FDA decisions: 8 (1983–1985): 8 510(k) clearances
- Product codes: JHI (2), KXT (1), ETD (1), KLI (1), CDP (1), JIX (1), KLS (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K853703: Ventrezyme T3 Immunoassay T3 (Oct 4, 1985)
- K853748: Ventrescreen HCG Urine (Oct 1, 1985)
- K841456: Ventrexyme Eia Controls Immunoassay (May 21, 1984)
- K840473: Ventrezyme T4 Immunoassay T4 (Apr 4, 1984)
- K833960: Ventrex Pregnancy Test Kit Enzyme (Feb 3, 1984)
- K833989: Ventrezyme Theophylline Immunoassay (Jan 30, 1984)
- K833878: Ventrezyme Digoxin Immunoassay Digox (Jan 13, 1984)
- K833909: Ventrescreen Beta-HCG Enzyme Immuno (Nov 21, 1983)

Source page: https://510kreport.com/company/vxr